4 news items
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
ABBV
CRBP
CRDL
14 May 24
Impacts
The rescheduling is likely to alleviate financial pressures on cannabis businesses, notably by eliminating certain tax burdens
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam?
PFE
13 May 24
dodged taxes despite high profits.
What Happened
Pfizer Reports First-Quarter 2024 Results
PFE
1 May 24
Effective Tax Rate
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
ABBV
ANIX
BIIB
20 Mar 24
a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice
- Prev
- 1
- Next